NCT06691568 is a NA clinical trial of Air purifier in Cat Allergy, sponsored by Dyson Technology Ltd.

Who is sponsoring NCT06691568?

NCT06691568 is sponsored by Dyson Technology Ltd.

What drugs are being tested in NCT06691568?

Interventions in NCT06691568: Air purifier.

What condition does NCT06691568 study?

NCT06691568 studies Cat Allergy.

Is NCT06691568 still recruiting?

NCT06691568 is currently completed. Last updated 15 November 2024.

Last reviewed 2024-11-15 · How we verify

NCT06691568

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effectiveness of an Air Purifier on Asthmatic and Cat-allergic Subjects in the ALYATEC Environmental Exposure Chamber

Completed NA Last updated 15 November 2024

What this trial tests

NA trial testing Air purifier in Cat Allergy in 30 participants. Completed in 26 October 2023.

Timeline

20 January 2023

Primary endpoint
26 October 2023

26 October 2023

Quick facts

Lead sponsor	Dyson Technology Ltd
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	supportive care
Enrollment	30
Start date	20 January 2023
Primary completion	26 October 2023
Estimated completion	26 October 2023
Sites	1 location across France

Drugs / interventions tested

Air purifier

Conditions studied

Cat Allergy — all drugs for Cat Allergy →

Sponsor

Dyson Technology Ltd

Who can join

Adults 18 to 65, any sex, with Cat Allergy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical trial is to evaluate the efficacy of air purifiers in reducing allergy symptoms in patients with a cat allergy. The main question it aims to answer is: If there is a reduction of early asthmatic response (EAR) compared to placebo. Participants were asked to remain in an exposure chamber for 2 hours while their symptoms were monitored.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Air purifier

Trials testing the same drug.

NCT06534385 — The Clean Air Study: HEPA Purifiers to Improve Indoor Air Quality and Health in Rural Alaska Homes · NA · recruiting
NCT05172388 — Indoor Air Filtration and Young Adults Health Study · NA · completed
NCT04252235 — Home Air Purification for Eosinophilic COPD · NA · completed
NCT03319056 — Indoor Air and Children Health Study · NA · completed
NCT03301402 — Air Purifier to Improve Endothelial Function and Carotid Intima Thickness · NA · completed

Other recruiting trials for Cat Allergy

Currently open trials in the same condition.

NCT05331170 — Viral Mucosal Reprogramming · Phase 2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06691568 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Dyson Technology Ltd
Last refreshed: 15 November 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06691568.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing